NINR Funding Opportunities and Updates - 

Extramural Program Newsletter

This monthly newsletter for NINR applicants and awardees provides information about funding initiatives and other opportunities. View all recent Notices of Funding Opportunities (NOFOs) via the NIH Guide.

NINR-led Funding Opportunities

• PAR-24-061: Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed) supports the development and implementation of short courses to prepare nurse scientists, and scientists in aligned fields, to conduct firearm injury prevention research in support of the NINR Strategic Plan. Next Application Due Date: May 25, 2024
• NOT-NR-23-012: Notice of Special Interest (NOSI): Addressing Organizational Factors to Prevent or Mitigate Nurse Burnout seeks research studies to develop and evaluate novel organizational interventions to prevent and mitigate nurse burnout which will build new knowledge and the evidence base for implementation in places where nurses practice: in hospitals and clinics, in schools and workplaces, in homes and long-term care facilities, in justice settings, and throughout communities. Next Application Due Date: June 5, 2024 
• RFA-NR-24-001: Firearm Injury Prevention in Community Healthcare Settings (R01 Clinical Trial Optional) seeks to advance research that reduces firearm injury and disparities through the development and evaluation of firearm injury primary prevention interventions leveraging community healthcare settings. Application Due Date: July 26, 2024

NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity 

• PAR-22-230: (R01 Clinical Trial Optional) solicits R01 grant applications that propose independent research projects that are consistent with the scientific framework detailed in the NINR Strategic Plan. Next Application Due Date: June 5, 2024
  • Please see Notice of Clarification NOT-NR-23-006 regarding Non-Responsive Applications. Updates shown in bold italics.
• PAR-22-231: (R21 Clinical Trial Optional) solicits R21 grant applications that propose exploratory/developmental research projects that are consistent with the research framework detailed in the NINR Strategic Plan. Next Application Due Date: June 16, 2024
  • Please see Notice of Clarification NOT-NR-23-007 regarding Non-Responsive Applications. Updates shown in bold italics.

This research will be rooted in nursing's holistic, contextualized approach to understanding people and their health, address the nation's most pressing and persistent health challenges with a solutions orientation, and employ innovative and rigorous study designs to inform practice and policy.

Participating Funding Opportunities

• PAR-24-110: Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) will support non-pharmacological interventions to promote sleep health, reduce sleep health disparities, and examine sleep as a modifiable factor to reduce disparities for other health outcomes among populations that experience health disparities. First Application Due Date: October 5, 2024

• Mentored Research Scientist Development Award (Parent K01) provides support and “protected time” (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. First Application Due Date: June 12, 2024

  • PA-24-175: Independent Clinical Trial Required

  • PA-24-176: Independent Clinical Trial Not Allowed

  • PA-24-177: Independent Basic Experimental Studies with Humans Required

• NIH Pathway to Independence Award (Parent K99/R00) facilitates a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. First Application Due Date: June 12, 2024

  • PA-24-193: Independent Clinical Trial Required

  • PA-24-194: Independent Clinical Trial Not Allowed

  • PA-24-195: Independent Basic Experimental Studies with Humans Required

• Midcareer Investigator Award in Patient-Oriented Research (Parent K24) provides support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors for junior clinical investigators pursuing POR research, such as clinical residents. First Application Due Date: June 12, 2024

  • PA-24-187: Independent Clinical Trial Required

  • PA-24-188: Independent Clinical Trial Not Allowed

  • PA-24-189: Independent Basic Experimental Studies with Humans Required

• Small Business Transition Grant for New Entrepreneurs (R43/R44). NIH and CDC aim to foster the advancement and accelerate the growth of early-career scientists transitioning to entrepreneurship by simultaneously supporting their entrepreneurial development and the conduct of research and development under their direction. First Application Due Date: September 5, 2024

  • PAR-24-131: Clinical Trial Not Allowed

  • PAR-24-132: Clinical Trial Required

• Small Business Transition Grant for New Entrepreneurs (R41/R42). NIH aims to foster the advancement and accelerate the growth of early-career scientists transitioning to entrepreneurship by simultaneously supporting their entrepreneurial development and the conduct of research and development under their direction. First Application Due Date: September 5, 2024

  • PAR-24-133: Clinical Trial Not Allowed

  • PAR-24-134: Clinical Trial Required

• Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15) supports small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions. First Application Due Date: June 25, 2024

  • PAR-24-152: Clinical Trial Not Allowed

  • PAR-24-214: Clinical Trial Required

• NOT-OD-24-079: Notice of Special Interest: Women’s Health Research, in alignment with the White House Initiative on Women’s Health Research, highlights interest in receiving research applications focused on diseases and health conditions that predominantly affect women (e.g., autoimmune diseases; depressive disorders, Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD), gender-based-violence), present and progress differently in women (e.g., cardiovascular disease; HIV; reproductive aging and its implications), or are female-specific (e.g., uterine fibroids; endometriosis; menopause). Next Application Due Date: June 5, 2024

• PAR-23-309: Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional) will support novel and innovative research that examines and/or intervenes on the underlying and multilevel causes, pathways, and factors adversely impacting the health and well-being of persons with disabilities at the intersections of race and ethnicity, and socioeconomic status. First Application Due Date: June 5, 2024
• NOT-CA-24-031: Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research encourages grant applications to support the evaluation of the utility and validity of digital health and artificial intelligence/machine learning (AI/ML) tools and technologies in biomedical and behavioral research. Next Application Due Date: June 5, 2024
• NOT-OD-24-058: Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being supports highly innovative multi-level interventions to increase and maintain health-enhancing physical activity in a wide range of population groups, including populations that experience health disparities, children, older adults, and persons at risk for mental/behavioral health conditions, and any subpopulations that can be characterized by the intersection of two or more of these descriptors. First Application Due Date: June 5, 2024
• PAR-23-303: Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) will support innovative, collaborative, and interdisciplinary research focused on clinical epidemiology, evaluation of public and/or health care policies, and validation of measurements that address health and healthcare disparities related to non-communicable and chronic diseases with the highest disease burden and mortality in Latin America and among U.S. Hispanics/Latinos. First Application Due Date: June 5, 2024

• PAR-23-304: Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) will support innovative and interdisciplinary team research focused on clinical, health services, and/or community-based interventions that address health and healthcare disparities related to non-communicable and chronic diseases with the highest disease burden and mortality in Latin America and among U.S. Hispanics/Latinos. First Application Due Date: June 5, 2024

• PAR-24-059: Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional) will support multidisciplinary and innovative intervention research to understand and address maternal morbidity and mortality in the U.S., particularly but not exclusively among racial and ethnic minority, socioeconomically disadvantaged, and underserved rural populations, with a focus on understudied healthcare factors. First Application Due Date: June 5, 2024

• NOT-OD-24-038: Notice of Special Interest: Health Influences of Gender as a Social and Structural Variable highlights interest in receiving research and training grant applications focused on health impacts of gender-related social and structural variables. First Available Due Date: June 5, 2024
• NOT-NR-24-002: Notice of NINR’s Scientific Interests for PAR-23-137, “NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)” informs applicants that NINR is updating PAR-23-137 to add the NINR Scientific Interests. Next Application Due Date: June 7, 2024
• RFA-MD-24-006: Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more populations that experience health disparities. First Application Due Date: June 10, 2024
• RFA-MD-24-007: Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined populations that experience health disparities. First Application Due Date: June 10, 2024

• PA-24-184: Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Clinical Trial Required) specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial. First Application Due Date: June 12, 2024

• PA-24-185: Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Clinical Trial Not Allowed) to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research. First Application Due Date: June 12, 2024
• PA-24-186: Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Basic Experimental Studies with Humans Required) for basic science experimental studies involving humans. First Application Due Date: June 12, 2024
• RFA-AA-24-006: Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required) supports the planning phase of the Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority Communities. MCCI is a multi-ICO dissemination and implementation science initiative to advance racial equity and end health disparities in racial/ethnic minority women and girls of reproductive age. First Application Due Date: June 18, 2024
• PAR-24-038: Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed) solicits applications to conduct institutional climate assessments using validated survey instruments and to develop action plans for positive change in the recruitment, hiring, retention, and advancement of faculty, including those from groups underrepresented in biomedical and behavioral research. First Application Due Date: July 1, 2024
• RFA-AG-25-002: Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional) invites applications proposing the development of a specialized center, which will provide resources, expertise, and coordination to advance innovative, high-quality research on palliative care for those living with serious illnesses across the lifespan. Application Due Date: July 2, 2024
• PAR-24-053: Multi-sectoral Preventive Interventions that Address Social Determinants of Health in Populations that Experience Health Disparities (UG3/UH3, Clinical Trial Required) supports projects to test prospective multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities. Application Due Date: August 5, 2024

• PAR-23-285: Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) will support planning and development, including pilot or feasibility research, to improve health in Native American populations. Proposed research may address health promotion, disease prevention, treatment, recovery, or services research to inform intervention implementation and dissemination. First Application Due Date: October 21, 2024

• PAR-23-298: Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) will support research on interventions to improve health in Native American populations. This includes 1) etiologic research that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests interventions for health promotion, prevention, treatment, or recovery, and 3) where a sufficient body of knowledge on intervention efficacy exists, research on dissemination and implementation that develops and tests strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. First Application Due Date: October 21, 2024

• PAR-23-299: Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) will support developmental/exploratory research to improve health in Native American populations. This includes 1) etiologic research that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests interventions for health promotion, prevention, treatment, or recovery, and 3) where a sufficient body of knowledge on intervention efficacy exists, research on strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. First Application Due Date: October 21, 2024

• NOT-OD-23-170: NOSI: Research Supplements to Promote Re-Entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed) will fund administrative supplements to provide full or part-time mentored research training experiences for individuals with high potential to re-enter, re-integrate into, or re-train in an active research career after an interruption for family responsibilities or other qualifying circumstances as described in the NOSI. NINR accepts administrative supplements on a rolling basis.

Events and Programs

Apply to NINR's SDOH Summer Research Institute

NINR invites prospective participants to submit letters of interest for our first SDOH Summer Research Institute, a new event designed to provide early and mid-career investigators the opportunity to learn more about and apply the principles of high-quality SDOH research. Submissions Due: May 28, 2024. Read More.  

Applicant Assistance Program (AAP)

A free, guided 10-week program designed to provide support and guidance to first-time small business applicants. One of the main goals of the AAP is to increase participation in the SBIR and STTR programs by businesses that are owned or controlled by individuals who are traditionally underrepresented in biomedical sciences. Submissions accepted from April 25, 2024 through May 21, 2024. Learn more.